Free Trial

Two Sigma Investments LP Lowers Stock Position in HealthStream, Inc. (NASDAQ:HSTM)

HealthStream logo with Computer and Technology background

Two Sigma Investments LP decreased its position in HealthStream, Inc. (NASDAQ:HSTM - Free Report) by 49.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 28,890 shares of the technology company's stock after selling 28,116 shares during the period. Two Sigma Investments LP owned about 0.09% of HealthStream worth $919,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in HSTM. Vanguard Group Inc. grew its holdings in shares of HealthStream by 3.1% during the fourth quarter. Vanguard Group Inc. now owns 3,055,060 shares of the technology company's stock worth $97,151,000 after buying an additional 92,067 shares in the last quarter. Geode Capital Management LLC increased its holdings in HealthStream by 2.9% during the 4th quarter. Geode Capital Management LLC now owns 694,274 shares of the technology company's stock worth $22,082,000 after purchasing an additional 19,510 shares during the period. Northern Trust Corp grew its holdings in HealthStream by 13.4% during the 4th quarter. Northern Trust Corp now owns 306,440 shares of the technology company's stock worth $9,745,000 after acquiring an additional 36,239 shares in the last quarter. Cerity Partners LLC increased its holdings in HealthStream by 3,889.2% in the fourth quarter. Cerity Partners LLC now owns 300,070 shares of the technology company's stock valued at $9,534,000 after buying an additional 292,548 shares during the last quarter. Finally, Invesco Ltd. boosted its holdings in shares of HealthStream by 11.5% in the 4th quarter. Invesco Ltd. now owns 248,221 shares of the technology company's stock valued at $7,893,000 after buying an additional 25,519 shares in the last quarter. 69.58% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on HSTM. William Blair reiterated an "outperform" rating on shares of HealthStream in a research report on Tuesday, February 25th. Canaccord Genuity Group dropped their price target on HealthStream from $30.00 to $29.00 and set a "hold" rating on the stock in a research note on Thursday, May 15th. Two investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, HealthStream presently has an average rating of "Moderate Buy" and a consensus price target of $31.50.

Read Our Latest Analysis on HealthStream

HealthStream Stock Down 0.3%

NASDAQ:HSTM traded down $0.09 during trading hours on Tuesday, reaching $28.13. 210,033 shares of the company's stock were exchanged, compared to its average volume of 148,880. HealthStream, Inc. has a 1-year low of $25.84 and a 1-year high of $34.24. The firm has a market capitalization of $858.67 million, a price-to-earnings ratio of 43.28, a P/E/G ratio of 4.37 and a beta of 0.43. The company has a 50-day moving average of $30.06 and a 200 day moving average of $31.58.

HealthStream (NASDAQ:HSTM - Get Free Report) last announced its earnings results on Monday, May 5th. The technology company reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.16 by ($0.02). HealthStream had a net margin of 6.84% and a return on equity of 5.67%. The business had revenue of $73.49 million during the quarter, compared to analysts' expectations of $74.93 million. During the same period in the previous year, the company posted $0.17 earnings per share. Research analysts forecast that HealthStream, Inc. will post 0.63 EPS for the current fiscal year.

HealthStream Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 30th. Shareholders of record on Monday, May 19th were given a dividend of $0.031 per share. The ex-dividend date of this dividend was Monday, May 19th. This represents a $0.12 dividend on an annualized basis and a yield of 0.44%. HealthStream's payout ratio is 19.05%.

HealthStream declared that its Board of Directors has approved a share buyback program on Thursday, May 8th that permits the company to buyback $25.00 million in shares. This buyback authorization permits the technology company to buy up to 3% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board believes its shares are undervalued.

HealthStream Profile

(Free Report)

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.

See Also

Institutional Ownership by Quarter for HealthStream (NASDAQ:HSTM)

Should You Invest $1,000 in HealthStream Right Now?

Before you consider HealthStream, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthStream wasn't on the list.

While HealthStream currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines